End-To-End Services In Contract Manufacturing

IDT Biologika, a part of SK Bioscience, is a globally operating contract development and manufacturing organization (CDMO) specializing in comprehensive, end-to-end services for the development and production of biologics, biosimilars, and other sterile injectable modalities.

Our capabilities span process and analytical development, drug substance manufacturing at scales ranging from 200L to 2,000L, as well as aseptic fill-finish and packaging, supported entirely by in-house analytical services. We offer expertise across a broad range of modalities, including cell-culture and microbial proteins, enzymes, viral vectors, vaccines, cell and gene therapeutics, oncolytic viruses, monoclonal antibodies, and biosimilars.

At IDT Biologika, we are committed to empowering our customers by delivering innovative solutions that advance their products and respond to the ever-evolving demands of global healthcare. Our vision reflects our steadfast commitment to excellence, innovation, and trusted partnerships. By working closely with our customers, we aim to drive progress, foster collaboration, and contribute to building a healthier world for all.